Epidermal Growth Factor Receptor (EGFR) Phosphorylation, Signaling and Trafficking in Prostate Cancer

QR Code

Epidermal Growth Factor Receptor (EGFR) Phosphorylation, Signaling and Trafficking in Prostate Cancer

None

Saved in:

Bibliographic Details
Main Authors:	Huang, Yao, Chang, Yongchang
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24224
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Endocytic Trafficking of the Epidermal Growth Factor Receptor in Transformed Cells
by: Ceresa, Brian P.
Published: (2011)

EGFRp4 Peptides: A Novel Strategy for Epidermal Growth Factor Receptor (EGFR) Inhibitor
by: Nattanan Jiwacharoenchai, et al.
Published: (2025-06-01)

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01)

Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer
by: Xin Dai, et al.
Published: (2025-07-01)

Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors
by: Huang-Chih Chang, et al.
Published: (2017-03-01)

OPTIMAL SEQUENCE OF APPLICATION OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVATING EGFR MUTATIONS
by: A. A. Kolomeytseva, et al.
Published: (2020-12-01)

TINGKAT KETAHANAN HIDUP 2 TAHUN PASIEN ADENOKARSINOMA PARU BERDASARKAN SIFAT MUTASI GEN EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR)
by: Muhammad Agung Wibowo Wicaksono, et al.
Published: (2020-01-01)

A novel epidermal growth factor receptor inhibitor for treating lung cancer
by: Jiansheng Gao, et al.
Published: (2017-03-01)

Molecular Docking Study: Application to the Epidermal Growth Factor Receptor
by: Faiza Asli, et al.
Published: (2024-11-01)

Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway
by: Mingdi Zhang, et al.
Published: (2017-04-01)

The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancer
by: Karen Bartley, et al.
Published: (2025-12-01)

Human epidermal growth factor receptor 2 expression and associated factors in endometrial carcinoma
by: Shiyun ZHANG, et al.
Published: (2025-06-01)

The Role of Cyclooxygenase-2, Epidermal Growth Factor Receptor and Aromatase in Malignant Mesothelioma
by: Galati, Rossella
Published: (2012)

Antitumor effect of a new human epidermal growth factor receptor inhibitor
by: O. I. Kit, et al.
Published: (2024-09-01)

Human Epidermal Growth Factor (Her) in Gastric Cancer
by: Czyzewska, Jolanta
Published: (2011)

Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients
by: Xiu-Qin Shi, et al.
Published: (2017-02-01)

The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells
by: D. A. Karseladze, et al.
Published: (2014-08-01)

Signaling by intracellular β2-adrenergic receptors regulates AMPA receptor trafficking and synaptic plasticity
by: Boram Lee, et al.
Published: (2025-08-01)

HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) IN GASTRIC CANCER (GC) (RESULTS OF THE MULTICENTER CLINICAL TRIAL)
by: H. C. Chung, et al.
Published: (2017-02-01)

Future Perspectives of Enhancing the Therapeutic Efficacy of Epidermal Growth Factor Receptor Inhibition in Malignant Gliomas
by: Karpel-Massler, Georg, et al.
Published: (2012)

Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma.
by: Venkata Ramesh Dasari, et al.
Published: (2012-01-01)

Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor (EGF) in Papillary Thyroid Cancer
by: Konturek, Aleksander, et al.
Published: (2012)

Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
by: Shaohua Cui, et al.
Published: (2017-04-01)

Correction: Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer
by: Ricardo Ribas, et al.
Published: (2025-06-01)

Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
by: Adeolu S. Oluremi, et al.
Published: (2025-07-01)

Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
by: O.M. Smorodska, et al.
Published: (2021-06-01)

Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem
by: A. S. Polonskaia, et al.
Published: (2022-02-01)

Retraction: Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma.
by: PLOS One Editors
Published: (2025-01-01)

Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies
by: Quistini A, et al.
Published: (2025-06-01)

The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
by: Li Yingying, et al.
Published: (2025-07-01)

Clinical Prognosis and Nomograms for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Patients Treated with Palbociclib and Endocrine Therapy
by: Song S, et al.
Published: (2025-07-01)

Advances in Targeted Therapy for Brain Metastases in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: A Focus on ADCs and TKIs
by: Rao B, et al.
Published: (2025-05-01)

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.
by: Zhixuan Zhang, et al.
Published: (2014-01-01)

EFFICACY EVALUATION OF A MONOCLONAL ANTIBODY AGAINST THE EPIDERMAL GROWTH FACTORS RECEPTOR IN THE MODEL OF SUBCUTANEOUS XENOGRAFT IN IMMUNODEFICIENT MICE
by: Ya. Yu. Ustyugov, et al.
Published: (2016-02-01)

Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
by: Marianne Nordlund Broughton, et al.
Published: (2017-06-01)

Epidermal Growth factor in human urine as promotor for the growth of Leishmania sp. In vitro.
by: Nuha S. Al-Bayatii, et al.
Published: (2023-02-01)

EGFR-Ligand Signaling in Breast Cancer Metastasis: Recurring Developmental Themes
by: Nickerson, Nicole K., et al.
Published: (2011)

Corrigendum to: Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway
by: Wang Shenglin, et al.
Published: (2025-06-01)

A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation‐Positive Non‐Small‐Cell Lung Cancer
by: Tomoki Tamura, et al.
Published: (2025-07-01)

Recent Management of Patients with Advanced Epidermal Growth Factor Receptor Mutation Non-small Cell Lung Cancer: Role of Afatinib and Lesson Learned for Developing Countries
by: Zulkifli Amin, et al.
Published: (2017-05-01)